PSMLX
Price
$31.19
Change
+$0.06 (+0.19%)
Updated
Nov 18 closing price
Net Assets
2.2B
VSCIX
Price
$117.69
Change
+$0.23 (+0.20%)
Updated
Nov 18 closing price
Net Assets
161.58B
Interact to see
Advertisement

PSMLX vs VSCIX

Header iconPSMLX vs VSCIX Comparison
Open Charts PSMLX vs VSCIXBanner chart's image
Principal SmallCap R6
Price$31.19
Change+$0.06 (+0.19%)
VolumeN/A
Net Assets2.2B
Vanguard Small Cap Index I
Price$117.69
Change+$0.23 (+0.20%)
VolumeN/A
Net Assets161.58B
PSMLX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
PSMLX vs. VSCIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSMLX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 162B vs. PSMLX (2.2B). VSCIX pays higher dividends than PSMLX: VSCIX (1.35) vs PSMLX (0.34). PSMLX was incepted earlier than VSCIX: PSMLX (9 years) vs VSCIX (28 years). PSMLX (0.74) is less costly to investors than VSCIX (0.04). PSMLX is a more actively managed with annual turnover of: 41.10 vs. VSCIX (13.00). PSMLX has a lower initial minimum investment than VSCIX: PSMLX (0) vs VSCIX (5000000). PSMLX annual gain was more profitable for investors over the last year : 4.63 vs. VSCIX (-0.53). VSCIX return over 5 years is better than : 39.21 vs. PSMLX (24.73).
PSMLXVSCIXPSMLX / VSCIX
Total Expense Ratio0.740.041,850%
Annual Report Gross Expense Ratio0.740.041,850%
Fund Existence9 years28 years-
Gain YTD9.4202.250419%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B162B1%
Annual Yield % from dividends0.341.3525%
Returns for 1 year4.63-0.53-865%
Returns for 3 years23.5829.8679%
Returns for 5 years24.7339.2163%
Returns for 10 yearsN/A122.35-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHSZX50.77N/A
N/A
PGIM Jennison Health Sciences Z
HAGAX72.32N/A
N/A
Carillon Eagle Mid Cap Growth A
EEMDX9.96N/A
N/A
MFS Emerging Markets Equity Research R1
FEQAX14.74N/A
N/A
Fidelity Advisor Hedged Equity A
ECSMX10.12N/A
N/A
Eaton Vance Small-Cap C